Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and proadifen

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with proadifen in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(proadifen)
Trials
(proadifen)
Recent Studies (post-2010) (proadifen)
9,1561875521,481035

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)proadifen (IC50)
Sigma non-opioid intracellular receptor 1Homo sapiens (human)1.5849
Aldehyde oxidase 1 Rattus norvegicus (Norway rat)1.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aepfelbacher, M; Lux, I; Weber, C; Weber, PC; Zimmer, B1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and proadifen

ArticleYear
Docosahexaenoic acid inhibits PAF and LTD4 stimulated [Ca2+]i-increase in differentiated monocytic U937 cells.
    Biochimica et biophysica acta, 1991, Dec-03, Volume: 1133, Issue:1

    Topics: Animals; Calcium; Cell Differentiation; Cell Line; Cytochrome P-450 Enzyme Inhibitors; Docosahexaenoic Acids; Fatty Acids, Unsaturated; Masoprocol; Monocytes; Phospholipids; Platelet Activating Factor; Proadifen; SRS-A; Tretinoin

1991